Search

everythinglearnresearchcommunity

for

Search:↓

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

Epidermal stem cells could lead to new treatments for skin and hair disorders.

Sunlight worsens hair loss; protect scalp.

Most hair follicle stem cells do not protect their DNA by dividing it unevenly.

Hair analysis can detect drug use but requires careful interpretation due to its complexity.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Skin grafts are effective for chronic leg ulcers, especially autologous split-thickness grafts for venous ulcers, but more data is needed for diabetic ulcers.

Spironolactone is an effective and well-tolerated first-line treatment for hidradenitis suppurativa in women.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Scarring alopecia affects different hair follicle stem cells than nonscarring alopecia, and the infundibular region could be a new treatment target.

Chemotherapy often causes patterned hair loss, with some scalp areas more resistant to hair loss than others.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Dupilumab may cause hair loss in some patients with severe atopic dermatitis.

Dupilumab may cause significant hair loss, which can reverse after stopping the drug.

Wnt10b helps blood stem cells grow after injury.

Men with a family history of hair loss are more likely to experience it themselves, especially if both parents have hair loss.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Hair pain is more common in women with hair loss, but it's not linked to the cause or severity of hair loss.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Understanding the genetics of rare inherited ichthyosis syndromes is key for better treatments and genetic counseling.

Ludwig pattern hair loss in women results from varying sensitivity in hair follicles, causing fewer visible hairs.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

People with hair loss conditions experience more anxiety, depression, and a lower quality of life than those without these conditions.

Researchers established normal hair and scalp characteristics for healthy women using trichoscopy.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Hair loss in secondary syphilis is more common than thought and can be reversed with antibiotics.

Women with early hair loss have higher blood pressure and aldosterone; screening and treatment may help.